Smart ECG device could help kidney patients dodge dangerous potassium spikes

NCT ID NCT06901960

Recruiting now Disease control Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 30 times

Summary

This study tests whether a portable, AI-enhanced ECG device can help people with moderate-to-advanced chronic kidney disease avoid dangerously high potassium levels (hyperkalemia). Participants will measure their potassium at home at least twice a week using the device and receive alerts if levels are abnormal. The goal is to reduce the number of high potassium episodes over six months, compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 3B-5) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hubei Provincial Hospital of TCM
NOT_YET_RECRUITING

Wuhan, Hubei, 430063, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Peking University First Hospital
RECRUITING

Beijing, Beijing Municipality, 100034, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The First Affiliated Hospital of Guangxi Medical University
NOT_YET_RECRUITING

Nanning, Guangxi, 530021, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHRONIC KIDNEY DISEASE (STAGES 3B-5) CHRONIC KIDNEY DISEASE (STAGES 3B-5)